Mystic Asset Management Inc. Buys 2,657 Shares of The Clorox Company (NYSE:CLX)

Mystic Asset Management Inc. increased its stake in shares of The Clorox Company (NYSE:CLX) by 31.7% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,040 shares of the company’s stock after acquiring an additional 2,657 shares during the period. Mystic Asset Management Inc.’s holdings in Clorox were worth $1,793,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. State Street Corp grew its stake in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after buying an additional 245,525 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after acquiring an additional 33,970 shares during the period. Stifel Financial Corp grew its position in shares of Clorox by 1.7% in the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after acquiring an additional 37,967 shares during the period. Amundi raised its holdings in shares of Clorox by 42.6% in the 4th quarter. Amundi now owns 1,032,283 shares of the company’s stock valued at $165,816,000 after purchasing an additional 308,234 shares during the period. Finally, FMR LLC raised its holdings in shares of Clorox by 27.6% in the 3rd quarter. FMR LLC now owns 776,232 shares of the company’s stock valued at $126,456,000 after purchasing an additional 168,111 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of NYSE:CLX opened at $148.54 on Tuesday. The company’s 50 day moving average price is $154.01 and its two-hundred day moving average price is $160.17. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The firm has a market cap of $18.30 billion, a PE ratio of 40.58, a PEG ratio of 2.62 and a beta of 0.45. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the firm posted $2.16 EPS. Equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.29%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CLX shares. DA Davidson cut their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Barclays lifted their target price on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. JPMorgan Chase & Co. lifted their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Wells Fargo & Company upped their price objective on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.